Billionaire Profile
Pankaj Patel
Global Rank
#439

Image: President's Secretariat | GODL-India | via Wikimedia Commons

Pankaj Patel

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$8.01B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+1.26% (24h)
Age
72
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

Pankaj Patel is an Indian billionaire businessman and the Chairman of Zydus Lifesciences (formerly Cadila Healthcare), one of India's largest pharmaceutical companies. His career spans decades in the healthcare industry, marked by significant contributions to the development of affordable medicines and healthcare innovation. With a focus on research and development, Patel has led Zydus Lifesciences to become a global player, consistently ranked among the top pharmaceutical companies in India. His leadership has been instrumental in the development of breakthrough therapies and improving access to essential medicines.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Pankaj Ramanbhai Patel was born on March 16, 1953, in Bhadran, Gujarat, India. His early life was influenced by his family's involvement in the pharmaceutical industry. His father co-founded Cadila Laboratories in 1952, which later became Cadila Healthcare and then Zydus Lifesciences under Pankaj's leadership. He pursued a Bachelor of Pharmacy and a Master of Pharmacy from L.M. College of Pharmacy, Gujarat University, and later obtained a Bachelor of Arts in Science and Law from the University of Mumbai. This diverse educational background equipped him with a unique blend of scientific knowledge and business acumen.

Rise to Success

Patel joined Cadila Healthcare in 1976 and took charge in 1995 after a restructuring of the company. Under his leadership, the company experienced significant growth, expanding its product portfolio and global presence. Patel was instrumental in transforming Zydus Lifesciences into a leading pharmaceutical company. A key achievement was the development of Lipaglyn, the first Indian drug for high-cholesterol diabetics. Patel's strategic focus on generics, vaccines, and research has propelled Zydus to the forefront of the Indian pharmaceutical industry.

Key Business Strategies

Pankaj Patel's business strategies center on innovation, quality, and accessibility in pharmaceuticals. His leadership emphasizes the importance of research and development, driving the company's focus on producing affordable, high-quality medicines. His strategy includes strategic diversification, focusing on generics, vaccines, and research to ensure long-term sustainability. Patel also expanded Zydus Lifesciences' global footprint and made significant investments in healthcare innovation. Patel has emphasized the importance of building a strong company culture and valuing its people. He emphasizes that, "What we do tomorrow is more important than what we did yesterday.”

Philanthropy

Pankaj Patel is known for his philanthropic endeavors, focusing on healthcare and education initiatives in India. While specific donation amounts are often undisclosed, Patel is recognized for his commitment to giving back to society. Patel believes that philanthropic work is more than just donating funds, emphasizing the importance of non-monetary contributions like time, ideas, and volunteering.

Career Milestones

1976

Joined Cadila Laboratories

Joined his family's pharmaceutical business.

1995

Took charge of Cadila Healthcare

Assumed leadership after the company's restructuring.

2003

Best Pharma Man of the Year

Awarded by the Foundation of Indian Industry and Economists.

2013

Developed Lipaglyn

Launched the first Indian drug for high-cholesterol diabetics.

2017

Became President of FICCI

Served as the president of the Federation of Indian Chambers of Commerce and Industry.

2025

Padma Bhushan

Conferred with the Padma Bhushan, the country's third-highest civilian award.

Philanthropy & Social Impact

Healthcare and Education

Healthcare and Education Initiatives

Undisclosed

Supports various healthcare and educational projects in India.

Business Philosophy & Leadership

Notable Quotes

"What we do tomorrow is more important than what we did yesterday."

"Financial risk is always associated with drug discovery. But the benefit that a blockbuster drug can bring to the business can be phenomenal if you can take that risk."

Leadership Principles

Innovation and Quality

Emphasizes research and development to provide affordable, high-quality medicines.

People-Centric Approach

Believes in building a strong workplace culture by valuing employees.

Strategic Thinking

Focuses on strategic diversification and long-term sustainability.

Giving Back

Prioritizes philanthropy and community development.